Filing Details

Accession Number:
0001179110-13-001018
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-01-17 16:22:50
Reporting Period:
2013-01-16
Filing Date:
2013-01-17
Accepted Time:
2013-01-17 16:22:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113481 Medicines Co MDCO Pharmaceutical Preparations (2834) 043324394
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1427141 Bernard William O'connor 8 Sylvan Way
Parsippany NJ 07054
Chief Accounting Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-01-16 25,000 $19.98 46,933 No 4 M Direct
Common Stock Disposition 2013-01-16 25,000 $30.00 21,933 No 4 S Direct
Common Stock Acquisiton 2013-01-16 11,302 $7.31 33,235 No 4 M Direct
Common Stock Disposition 2013-01-16 11,302 $30.00 21,933 No 4 S Direct
Common Stock Acquisiton 2013-01-16 13,194 $17.45 35,127 No 4 M Direct
Common Stock Disposition 2013-01-16 13,194 $30.00 21,933 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Option (right to buy) Disposition 2013-01-16 25,000 $0.00 25,000 $19.98
Common Stock Common stock Disposition 2013-01-16 11,302 $0.00 11,302 $7.31
Common Stock Option (right to buy) Disposition 2013-01-16 13,194 $0.00 13,194 $17.45
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
75,000 2016-04-24 No 4 M Direct
6,198 2020-02-19 No 4 M Direct
20,139 2021-02-18 No 4 M Direct
Footnotes
  1. The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. O'Connor on March 10, 2011 as amended on March 16, 2012.
  2. As of 1/16/2013, the original grant (100,000 shares granted on 4/24/2006) was fully vested. After the exercise of the options reported hereby, as of 1/16/2013, the remaining 75,000 shares covered by this option are vested but not exercised.
  3. As of 1/16/2013, the original grant (17,500 shares granted on 2/19/2010)was vested with respect to 12,396 of the shares covered thereby and the remaining 5,104 shares covered by this option vest in equal monthly installments ending on 2/19/2014. After the exercise of the options reported hereby, as of 1/16/2013, 1,094 of the shares covered by the option were vested but not exercised.
  4. As of 1/16/2013, the original grant (33,333 shares granted on 2/18/2011) was vested with respect to 15,278 of the shares covered thereby and the remaining 18,055 shares covered by this option vest in equal monthly installments ending on 2/18/2015. After the exercise of the options reported hereby, as of 1/16/2013, 2,084 of the shares covered by the option were vested but not exercised.